Nonsteroidal anti-inflammatory drugs after acute myocardial infarction. DAVIT Study Group. Danish Verapamil Infarction Trial

A Sajadieh; O Wendelboe; J F Hansen; L S Mortensen

doi:10.1016/s0002-9149(99)00068-5

Nonsteroidal anti-inflammatory drugs after acute myocardial infarction. DAVIT Study Group. Danish Verapamil Infarction Trial

A Sajadieh, O Wendelboe, J F Hansen, L S Mortensen

Abstract

The effect of nonsteroid anti-inflammatory drugs (NSAIDs) after acute myocardial infarction was studied in a retrospective study of 88 patients who were receiving regular NSAID treatment at randomization in the Danish Verapamil Infarction Trial II. There were no significant differences in mortality or major events between NSAID-treated patients versus controls (1,687); however, in a multivariate analysis a nonsignificant beneficial trend in favor of NSAIDs was observed.

Original language	English
Journal	The American journal of cardiology
Volume	83
Issue number	8
Pages (from-to)	1263-5, A9
ISSN	0002-9149
DOIs	https://doi.org/10.1016/s0002-9149(99)00068-5
Publication status	Published - 15 Apr 1999

Keywords

Aged
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use
Calcium Channel Blockers/therapeutic use
Drug Therapy, Combination
Female
Follow-Up Studies
Humans
Male
Middle Aged
Myocardial Infarction/drug therapy
Prognosis
Prospective Studies
Safety
Secondary Prevention
Survival Rate
Verapamil/therapeutic use

Access to Document

10.1016/s0002-9149(99)00068-5

Cite this

@article{0ce5c7d5372048ec86a65648c07e779e,

title = "Nonsteroidal anti-inflammatory drugs after acute myocardial infarction. DAVIT Study Group. Danish Verapamil Infarction Trial",

abstract = "The effect of nonsteroid anti-inflammatory drugs (NSAIDs) after acute myocardial infarction was studied in a retrospective study of 88 patients who were receiving regular NSAID treatment at randomization in the Danish Verapamil Infarction Trial II. There were no significant differences in mortality or major events between NSAID-treated patients versus controls (1,687); however, in a multivariate analysis a nonsignificant beneficial trend in favor of NSAIDs was observed.",

keywords = "Aged, Anti-Inflammatory Agents, Non-Steroidal/therapeutic use, Calcium Channel Blockers/therapeutic use, Drug Therapy, Combination, Female, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Infarction/drug therapy, Prognosis, Prospective Studies, Safety, Secondary Prevention, Survival Rate, Verapamil/therapeutic use",

author = "A Sajadieh and O Wendelboe and Hansen, {J F} and Mortensen, {L S}",

year = "1999",

month = apr,

day = "15",

doi = "10.1016/s0002-9149(99)00068-5",

language = "English",

volume = "83",

pages = "1263--5, A9",

journal = "The American journal of cardiology",

issn = "0002-9149",

publisher = "Excerpta Medica, Inc",

number = "8",

}

TY - JOUR

T1 - Nonsteroidal anti-inflammatory drugs after acute myocardial infarction. DAVIT Study Group. Danish Verapamil Infarction Trial

AU - Sajadieh, A

AU - Wendelboe, O

AU - Hansen, J F

AU - Mortensen, L S

PY - 1999/4/15

Y1 - 1999/4/15

N2 - The effect of nonsteroid anti-inflammatory drugs (NSAIDs) after acute myocardial infarction was studied in a retrospective study of 88 patients who were receiving regular NSAID treatment at randomization in the Danish Verapamil Infarction Trial II. There were no significant differences in mortality or major events between NSAID-treated patients versus controls (1,687); however, in a multivariate analysis a nonsignificant beneficial trend in favor of NSAIDs was observed.

AB - The effect of nonsteroid anti-inflammatory drugs (NSAIDs) after acute myocardial infarction was studied in a retrospective study of 88 patients who were receiving regular NSAID treatment at randomization in the Danish Verapamil Infarction Trial II. There were no significant differences in mortality or major events between NSAID-treated patients versus controls (1,687); however, in a multivariate analysis a nonsignificant beneficial trend in favor of NSAIDs was observed.

KW - Aged

KW - Anti-Inflammatory Agents, Non-Steroidal/therapeutic use

KW - Calcium Channel Blockers/therapeutic use

KW - Drug Therapy, Combination

KW - Female

KW - Follow-Up Studies

KW - Humans

KW - Male

KW - Middle Aged

KW - Myocardial Infarction/drug therapy

KW - Prognosis

KW - Prospective Studies

KW - Safety

KW - Secondary Prevention

KW - Survival Rate

KW - Verapamil/therapeutic use

U2 - 10.1016/s0002-9149(99)00068-5

DO - 10.1016/s0002-9149(99)00068-5

M3 - Journal article

C2 - 10215295

SN - 0002-9149

VL - 83

SP - 1263-5, A9

JO - The American journal of cardiology

JF - The American journal of cardiology

IS - 8

ER -

Nonsteroidal anti-inflammatory drugs after acute myocardial infarction. DAVIT Study Group. Danish Verapamil Infarction Trial

Abstract

Keywords

Access to Document

Fingerprint

Cite this